12 May 2021
Clifford Chance advises Clayton, Dubilier & Rice on its $4bn public to private takeover bid for UDG Healthcare plc
Advising firms
Deal team
19 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Simon Tinkler Lead | Clifford Chance | Partner | Private Equity and Global Relationship | London |
| Katherine Moir Lead | Clifford Chance | Partner | Corporate | London |
| Jenny Storey Lead | Clifford Chance | Partner | Antitrust | London |
| Faeezah Tailor | Clifford Chance | Associate | Corporate and Private Equity | London |
| Abi Birch | Clifford Chance | Associate | Corporate and Private Equity | London |
| Tom Cowie | Clifford Chance | Associate | Corporate and Private Equity | London |
| Julia Lee | Clifford Chance | Associate | Corporate and Private Equity | London |
| Stavroula Vryna | Clifford Chance | Associate | Antitrust | London |
| Kabya Chaharia | Clifford Chance | Associate | Antitrust | London |
| Tim Cornell | Clifford Chance | Not stated | Not stated | Not stated |
| Abby Cessna | Clifford Chance | Not stated | Not stated | Not stated |
| Eva Kurban | Clifford Chance | Not stated | Not stated | Not stated |
| Daryl Fairbairn | Clifford Chance | Not stated | Not stated | Not stated |
| Jen Saionz | Clifford Chance | Not stated | Not stated | Not stated |
| Myra Garrett | William Fry | Partner | Not stated | Not stated |
| Brian Butterwick | William Fry | Partner | Not stated | Not stated |
| Lyn Brennan | William Fry | Partner | Not stated | Not stated |
| Jeff Ross | Debevoise & Plimpton | Partner | Not stated | Not stated |
| Paul Laszlo | Debevoise & Plimpton | Partner | Not stated | Not stated |
Stated terms
- Stated value
- USD 4bn (US$4bn)
- What the figure measures
- Total transaction value
- Client
- Clayton, Dubilier & RiceBuy-side
- Counterparties
- UDG Healthcare plc (Target)